Skip to main content
SpringerLink
Log in

Fish Oil Based Lipid Emulsions for the Treatment of Intestinal Failure Associated Liver Disease: Nothing Fishy About it!

  • Editorial Commentary
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Lacaille F, Gupte G, Colomb V, et al. ESPGHAN Working Group of Intestinal Failure and Intestinal Transplantation. Intestinal failure-associated liver disease: a position paper of the ESPGHAN Working Group of Intestinal Failure and Intestinal Transplantation. J Pediatr Gastroenterol Nutr. 2015;60:272.

  2. Miura W, Nagano N, Kato R, et al. Intestinal failure-associated liver disease and eicosapentaenoic acid/arachidonic acid ratio. Indian J Pediatr 2019 Feb 13. https://doi.org/10.1007/s12098-019-02895-7. [Epub ahead of print].

  3. Hojsak I, Colomb V, Braegger C, et al. ESPGHAN Committee on Nutrition. ESPGHAN Committee on Nutrition Position Paper. Intravenous lipid emulsions and risk of hepatotoxicity in infants and children: a systematic review and meta-analysis. J Pediatr Gastroenterol Nutr. 2016;62:776.

  4. Park HW, Lee NM, Kim JH, Kim KS, Kim SN. Parenteral fish oil-containing lipid emulsions may reverse parenteral nutrition-associated cholestasis in neonates: a systematic review and meta-analysis. J Nutr. 2015;145:277.

    Article  CAS  PubMed  Google Scholar 

  5. Lam HS, Tam YH, Poon TC, et al. A double-blind randomised controlled trial of fish oil-based versus soy-based lipid preparations in the treatment of infants with parenteral nutrition-associated cholestasis. Neonatology. 2014;105:290.

    Article  CAS  PubMed  Google Scholar 

  6. Wang C, Venick RS, Shew SB, et al. Long-term outcomes in children with intestinal failure-associated liver disease treated with 6 months of intravenous fish oil followed by resumption of intravenous soybean oil. J Parenter Enter Nutr. 2018 Nov 8. https://doi.org/10.1002/jpen.1463 [Epub ahead of print].

  7. Norsa L, Nicastro E, Di Giorgio A, Lacaille F, D'Antiga L. Prevention and treatment of intestinal failure-associated liver disease in children. Nutrients. 2018;10:664.

    Article  CAS  PubMed Central  Google Scholar 

  8. Belza C, Thompson R, Somers GR, et al. Persistence of hepatic fibrosis in pediatric intestinal failure patients treated with intravenous fish oil lipid emulsion. J Pediatr Surg. 2017;52:795.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pediatric Gastroenterology, Department of Gastroenterology, PGIMER, Chandigarh, India

    Rishi Bolia

  2. Department of Pediatric Gastroenterology, SGPGIMS, Raebareli Road, Lucknow, Uttar Pradesh, 226014, India

    Anshu Srivastava

Authors
  1. Rishi Bolia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anshu Srivastava
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anshu Srivastava.

Ethics declarations

Conflict of Interest

None.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bolia, R., Srivastava, A. Fish Oil Based Lipid Emulsions for the Treatment of Intestinal Failure Associated Liver Disease: Nothing Fishy About it!. Indian J Pediatr 86, 494–495 (2019). https://doi.org/10.1007/s12098-019-02944-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-019-02944-1

Search

Navigation